Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Cer 32:2;O2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004167 AN006917 Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells Renal cancer cells Human Cancer The Affiliated Cancer Hospital of Zhengzhou University LC-MS
ST003051 AN005003 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST002054 AN003344 Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance Cultured cells Human Cancer Columbia University LC-MS
ST002047 AN003334 Lyso-lipid induced oligodendrocytes maturation underlie restoration of optic nerve function Cultured cells Rat Eye disease University of Miami LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
ST001210 AN002015 Comprehensive UHPLC-MS/MS lipidomics profiling to study effects of betulin on keratinocytes Keratinocytes Human Eberhard Karls University of Tübingen LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo